Bioterrorism and its impact on the emergency department

Clinical Pediatric Emergency Medicine

Volumn 3, Issue 4, 2002, Pages 231-238

  Kienstra, Andrew J ^a   Endom, Erin E ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BOTULINUM ANTISERUM; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SMALLPOX VACCINE; STREPTOMYCIN; TETRACYCLINE; TETRACYCLINE DERIVATIVE;

ANTHRAX; ARTHROPATHY; ARTICLE; BIOLOGICAL WARFARE; BOTULISM; CHILD; CIVIL DISORDER; EMERGENCY HEALTH SERVICE; EPIDEMIC; HOSPITAL PERSONNEL; HUMAN; INTERPERSONAL COMMUNICATION; LAW ENFORCEMENT; MEDICAL EDUCATION; PUBLIC HEALTH; RESCUE PERSONNEL; RESOURCE MANAGEMENT; SMALLPOX; STAFF TRAINING; TENDON DISEASE; TOOTH COLOR; UNITED STATES; VIRUS INFECTION;

EID: 0036962263     PISSN: 15228401     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1522-8401(02)90035-2     Document Type: Article

References (34)

1. Bush LM, Abrams BH, Beall A, et al: Index case of fatal inhalational anthrax due to bioterrorism in the United States. N Engl Med 22:1607-1610, 2001.
2. Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. MMWR Morb Mortal Wkly Rep 50:909-919, 2001.
3. Roche KJ, Chang MW, Lazarus H: Images in clinical medicine: Cutaneous anthrax infection. N Engl J Med 22:1611, 2001.
4. Update: Investigation of bioterrorism-related inhalational anthrax-Connecticut, 2001. Available at http:// www.cdc.gov/mmwr/preview/mmwrhtml/mm5047a1.htm
5. Bell DM, Kozarsky PE, Stephens DS: Conference summary: Clinical ussues in the prophylaxis, diagnosis, and treatment of anthrax. Emerg Infect Dis 8:222-225, 2002.
6. Centers for Disease Control: Notice to readers: Evaluation of postexposure antibiotic prophylaxis to prevent anthrax. Available at:
7. Swartz MN: Current concepts: Recognition and management of anthrax-an update. N Engl J Med 345: 1621, 2001.
8. APIC Bioterrorism Task Force and CDC Hospital Infections Program Bioterrorism Working Group: Bioterrorism Readiness Plan: A Template for Health Care Facilities. Available at:
9. Henretig FM, Cieslak TJ: Bioterrorism and pediatric emergency medicine. Clin Pediatr Emerg Med 2:211-222, 2001.
10. Consensus Panel Statements for Outcome-Effective and Evidence-Based Patient Management. Bioterrorism: An update for clinicians, pharmacists and emergency management planners. Emerg Med Consensus Reports 3-12, 2000.
11. Rosenthal M: ID physicians, ED staff are first line of defense against biological terrorism. Infect Dis Child 64-64, 1998.
12. Richards CF, Burstein JL, Waeckerle JF, et al: Emergency physicians and biological terrorism. Ann Emerg Med 34:183-190, 1999.
13. Biological and chemical terrorism: Strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Work-group. MMWR Morb Mortal Wkly Rep 49:1-14, 2000.
14. Patt HP, Feigin RD: Diagnosis and management of suspected cases of bioterrorism: A pediatric perspective. Pediatrics 109:685-692, 2002.
15. Robinson-Dunn B: The microbiology laboratory's role in response to bioterrorism. Arch Pathol Lab Med 126:291-294, 2002.
16. Jones TF, Craig AS, Hoy D, et al: Mass psychogenic illness attributed to toxic exposure at a high school. N Engl J Med 342:96-100, 2000.
17. Franke, J. A new war. Texas Med 96:33-39, 2000.
18. Miller JM: Agents of bioterrorism: Preparing for bioterrorism at the community health care level. Infect Dis Clin North Am 15:1127-1156, 2001.
19. Barthell EN, Cordell WH, Moorhead JC, et al: The frontlines of medicine project: A proposal for the standardized communication of emergency department data for public health uses including syndromic surveillance for biological and chemical terrorism. Ann Emerg Med 39:422-429, 2002.
20. Verton D: Bioterrorism fighters get ammo. Available at:
21. Alghasham AA, Nahata MC: Clinical use of flouroquinolones in children. Ann Pharmacother 34:347-359, 2000.
22. Redmond A, Sweeney L, MacFarland M, et al: Oral ciprofloxacin in the treatment of Pseudomonas exacerbations of paediatric cystic fibrosis: Clinical efficacy and safety evaluation using magnetic resonance imaging. J Int Med Res 26:304-312, 1998.
23. Singh UK, Sinha RK, Prasad B, et al: Ciprofloxacin in children: Is arthropathy a limitation? Ind J Pediatr 67:386-387, 2000.
24. Lochary ME, Lockhart, PB, Williams WT Jr: Doxycycline and staining of permanent teeth. Pediatr Infect Dis J 17:429-431, 1998.
25. Recommendations for antimicrobial prophylaxis for children and breastfeeding mothers and treatment of children with anthrax. JAMA 286:2663-2664, 2001.
26. Centers for Disease Control homepage: National Pharmaceutical Stockpile Program. Available at: http:// www.cdc.gov/nceh/nps/default.htm.
27. Reissman S: National Pharmaceutical Stockpile Program. Presented at the 23rd Annual International Disaster Management Conference, Orlando, FL, February 1, 2002.
28. Stern J: Anthrax incidents: Hoaxes and threats. National Symposium on Medical and Public Response to Bioterrorism Session on Domestic Terrorism, Washington DC, February 16, 1999.
29. Keim M, Kaufmann AF: Disaster medicine: Principle for emergency response to bioterrorism. Ann Emerg Med 34:177-182, 1999.
30. Eitzen EM: Education is the key defense against bioterrorism. Ann Emerg Med 34:221-223, 1999.
31. Pesik N, Keim M, Sampson TR: Do US emergency medicine residency programs provide adequate training for bioterrorism? Ann Emerg Med 34:173-176, 1999.
32. Waeckerle JF, Seamans Sm Whiteside M: Emergency medical services: Executive summary: Developing objectives, content, and competencies for the training of emergency medical technical, emergency physicians, and emergency nurses to care for casualties resulting from nuclear, biological, or chemical (NBC) incidents. Ann Emerg Med 37:587-601, 2001.
33. Rega P: Correspondence: Disaster medical education for all physicians and physician extenders, letter to the editor. Ann Emerg Med 35:314-315, 2000.
34. Children's hospital urge Congress to factor children's unique needs into bioterrorism aid. Available at: